Skip to main content
William Grobman, MD, Obstetrics & Gynecology, Chicago, IL, Ohio State University Wexner Medical Center

WilliamGrobmanMD

Obstetrics & Gynecology Chicago, IL

Maternal & Fetal Medicine/High Risk

Professor in OB/GYN-Maternal Fetal Medicine, Northwestern University Medical School

Dr. Grobman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Grobman's full profile

Already have an account?

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Maternal-Fetal Medicine, 1997 - 2000
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Obstetrics and Gynecology, 1993 - 1997
  • Harvard Medical School
    Harvard Medical SchoolClass of 1993

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2021 - 2025
  • IL State Medical License
    IL State Medical License 1993 - 2023
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Maternal-Fetal Medicine

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • 888 Markers of Maternal Morbidity in Nulliparous Women  
    David M Haas, William A Grobman, Ronald J Wapner, Uma M Reddy, American Journal of Obstetrics and Gynecology
  • 1072 Early Pregnancy BMI and Angiogenesis-Related Biomarkers (sFlt-1/PlGF): A Pathway for Adverse Pregnancy Outcomes?  
    William A Grobman, Uma M Reddy, Hyagriv Simhan, David M Haas, American Journal of Obstetrics and Gynecology
  • Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm P...  
    Michael J Paidas, George A Macones, Garrett K Lam, Everett F Magann, Erika F Werner, Mounira A Habli, Chad A Grotegut, Sherri A Longo, Erol Amon, William A Grobman, De..., American Journal of Obstetrics and Gynecology
  • Join now to see all

Authored Content

  • Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)August 2020
  • Effect of a Patient-Centered Decision Support Tool on Rates of Trial of Labor After Previous Cesarean DeliveryJune 2020
  • Effect of a Patient-Centered Decision Support Tool on Rates of Trial of Labor After Previous Cesarean DeliveryJune 2020
  • Health Resource Utilization of Labor Induction Versus Expectant ManagementJanuary 2020
  • Opioid Prescribing Patterns Among Postpartum WomenApril 2018
  • Associations of Neighborhood-Level Racial Residential Segregation with Adverse Pregnancy OutcomesFebruary 2018
  • Join now to see all

Press Mentions

  • Does Risk for Heart Disease Start Before Birth?
    Does Risk for Heart Disease Start Before Birth?February 13th, 2023
  • Gen Z and Millennials Twice as Likely to Develop Hypertension in Pregnancy
    Gen Z and Millennials Twice as Likely to Develop Hypertension in PregnancySeptember 6th, 2022
  • American Heart Association Awards $20 Million for Research to Improve Outcomes in Pregnancy, CVD Health
    American Heart Association Awards $20 Million for Research to Improve Outcomes in Pregnancy, CVD HealthJuly 12th, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations